BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11346660)

  • 1. HIV integrase, a brief overview from chemistry to therapeutics.
    Craigie R
    J Biol Chem; 2001 Jun; 276(26):23213-6. PubMed ID: 11346660
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV integrase: a target for AIDS therapeutics.
    Thomas M; Brady L
    Trends Biotechnol; 1997 May; 15(5):167-72. PubMed ID: 9161051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The integrase of the human immunodeficiency virus as a novel target for the antiviral therapy of AIDS.
    Witvrouw M; Debyser Z
    Verh K Acad Geneeskd Belg; 2003; 65(5):325-34. PubMed ID: 14671848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [How proviral DNA is integrated into the host cell DNA and how this process can be inhibited].
    Mirambeau G
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():11-6. PubMed ID: 19572420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diketo acids derivatives as integrase inhibitors: the war against the acquired immunodeficiency syndrome.
    Henao-Mejia J; Góez Y; Patiño P; Rugeles MT
    Recent Pat Antiinfect Drug Discov; 2006 Jun; 1(2):255-65. PubMed ID: 18221151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors.
    Pace P; Spieser SA; Summa V
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3865-9. PubMed ID: 18595690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 integrase inhibitors: update and perspectives.
    Semenova EA; Marchand C; Pommier Y
    Adv Pharmacol; 2008; 56():199-228. PubMed ID: 18086413
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV-1 integrase multimerization as a therapeutic target.
    Feng L; Larue RC; Slaughter A; Kessl JJ; Kvaratskhelia M
    Curr Top Microbiol Immunol; 2015; 389():93-119. PubMed ID: 25778682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.
    Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F
    J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in diketo-containing inhibitors of HIV-1 integrase.
    Zhao G; Wang C; Liu C; Lou H
    Mini Rev Med Chem; 2007 Jul; 7(7):707-25. PubMed ID: 17627583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV integrase inhibitors as therapeutic agents in AIDS.
    Nair V; Chi G
    Rev Med Virol; 2007; 17(4):277-95. PubMed ID: 17503547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 integrase: a target for new AIDS chemotherapeutics.
    Anthony NJ
    Curr Top Med Chem; 2004; 4(9):979-90. PubMed ID: 15134552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical screening assays to identify HIV-1 integrase inhibitors.
    Clynhens M; Smets A; Vereycken I; Van Loock M; Clayton R; Meersseman G; Goethals O
    Methods Mol Biol; 2013; 1030():25-36. PubMed ID: 23821258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An effective HIV-1 integrase inhibitor screening platform: Rationality validation of drug screening, conformational mobility and molecular recognition analysis for PFV integrase complex with viral DNA.
    Du W; Zuo K; Sun X; Liu W; Yan X; Liang L; Wan H; Chen F; Hu J
    J Mol Graph Model; 2017 Nov; 78():96-109. PubMed ID: 29055187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of integrase inhibitors of quinolone acid derivatives for treatment of AIDS: an overview.
    Luo ZG; Tan JJ; Zeng Y; Wang CX; Hu LM
    Mini Rev Med Chem; 2010 Oct; 10(11):1046-57. PubMed ID: 21044030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrase Resistance-Associated Mutations on Raltegravir Failure in Western India: A Preliminary Analysis.
    Pujari SN; Gaikwad S; Joshi K; Dabhade D; Sane S; Rao NP; Bele V
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):e42-e45. PubMed ID: 29315113
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV integrase as a target for antiviral chemotherapy.
    Nair V
    Rev Med Virol; 2002; 12(3):179-93. PubMed ID: 11987143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of novel bioisosteres of beta-diketo acid inhibitors of HIV-1 integrase.
    Sechi M; Sannia L; Carta F; Palomba M; Dallocchio R; Dessì A; Derudas M; Zawahir Z; Neamati N
    Antivir Chem Chemother; 2005; 16(1):41-61. PubMed ID: 15739621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrase inhibitors.
    García-Gasco P; Blanco F; Soriano V
    J HIV Ther; 2005 Dec; 10(4):75-8. PubMed ID: 16519247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.